 |
INVESTOR HOME
PRESS RELEASES
PRODUCT DEMONSTRATIONS
EVENTS & WEBCASTS
ANNUAL MEETING
INVESTOR KIT
INFORMATION REQUEST
FAQs
|
|
PRESS RELEASES
November 2, 2005
ADVENTRX to Present at November Conferences
October 21, 2005
ADVENTRX Announces Positive CoFactor Study Data at AACR Special Conference in Cancer Research
October 13, 2005
ADVENTRX to Present at the BIO InvestorForum 2005 on October 19
October 10, 2005
ADVENTRX Reports Patient Enrollment Progress with CoFactor Phase IIb Trial
October 6, 2005
ADVENTRX Reports Phase II CoFactor Trial Update
October 4, 2005
ADVENTRX Acquires Additional Oncology Drug Through Exclusive License Agreement
August 17, 2005
ADVENTRX to Present at the 2005 San Diego Growth Conference on
August 19
August 12, 2005
ADVENTRX Expands Board Membership
August 12, 2005
ADVENTRX Announces 2005 Second Quarter Financial Results
August 1, 2005
ADVENTRX Completes $20 Million Private Placement with Carl Icahn as Largest Investor
July 26, 2005
ADVENTRX Presents Positive Thiovir Data at IAS 2005 Conference
July 22, 2005
ADVENTRX Pharmaceuticals Raises $20 Million in Common Stock Private Placement with Carl Icahn as Largest Investor
July 5, 2005
ADVENTRX Joins the New Russell Microcap Index
June 20, 2005
ADVENTRX Presents Response Data for Total Enrollment
in CoFactor Phase II Metastatic Colorectal Cancer Trial
May 31, 2005
Patient Treatment Initiated in ADVENTRX International Phase IIb Metastatic Colorectal Cancer Trial
May 13, 2005
ADVENTRX Reports Positive Preliminary Phase II Trial Results with CoFactor in Metastatic Colorectal Cancer
May 13, 2005
ADVENTRX Announces 2005 First Quarter Financial Results
May 5, 2005
ADVENTRX's Preliminary Results for CoFactor Phase II Trial Published at ASCO
April 28, 2005
ADVENTRX to Present at Rodman & Renshaw Techvest
2nd Annual Global Healthcare Conference on May 5
April 25, 2005
ADVENTRX Receives FDA Clearance for CoFactor Phase III
Pivotal Trial in Metastatic Colorectal Cancer
April 19, 2005
ADVENTRX Presents Enhanced Antitumor Activity and Lower Systemic Toxicity with CoFactor Combination Therapies in Preclinical Models
April 19, 2005
ADVENTRX Presents CoFactor Toxicity and Pharmacodynamics Data from Phase II Trial
April 15, 2005
ADVENTRX Granted Clearance in the UK for CoFactor Phase IIB Metastatic Colorectal Cancer Trial
April 11, 2005
ADVENTRX'S CoFactor Phase II and Preclinical Toxicity Data to be Presented at AACR Annual Meeting
April 4, 2005
ADVENTRX Announces 2004 Fourth Quarter and Full Year Financial Results (Revised)
March 31, 2005
ADVENTRX Announces 2004 Fourth Quarter and Full Year Financial Results
March 29, 2005
ADVENTRX Receives CoFactor Pancreatic Cancer Clinical Design and Protocol Final Advice Letter from EMEA
March 7, 2005
ADVENTRX Announces Primary Endpoint
Met in Cofactor Phase II Metastatic Colorectal Cancer Trial
February 10, 2005
Bengt G. Gustavsson, M.D., Ph.D. To Chair ADVENTRX Scientific Advisory Board
January 25, 2005
Endpoints Met In First Stage Of ADVENTRX Cofactor Phase II Metastatic Colorectal Cancer Study
2004 Press Release Archive | 2003 Press Release Archive
|
|
|
